Inventor · disambiguated record
Steven P. Braithwaite
Also filed as: BRAITHWAITE STEVEN · BRAITHWAITE STEVEN P
12 granted patents·14 pending applications·70 citations·filing 2002–2023
90Inventor score
Files withALKAHEST INC16UNIV RUTGERS3AGY THERAPEUTICS INC2UNIV LELAND STANFORD JUNIOR2MENTINOVA INC1
Top patents by PatentIndex Score
26 records- 0194US10357513B2Dosing regimen for treatment of cognitive and motor impairments with blood plasma and blood plasma productsALKAHEST INC·Filed 2018·Granted Jul 23, 2019·17 cites·10 claims
- 0292US10905779B2Methods for screening human blood products comprising plasma using immunocompromised rodent modelsUNIV LELAND STANFORD JUNIOR·Filed 2017·Granted Feb 2, 2021·7 cites·16 claims
- 0392US10525107B2Blood plasma fractions as a treatment for aging-associated cognitive disordersALKAHEST INC·Filed 2017·Granted Jan 7, 2020·12 cites·8 claims
- 0489US10245285B2Blood plasma and plasma fractions as therapy for tumor growth and progressionALKAHEST INC·Filed 2017·Granted Apr 2, 2019·11 cites·18 claims
- 0587US10874692B2Dosing regimen for treatment of cognitive and motor impairments with blood plasma and blood plasma productsALKAHEST INC·Filed 2019·Granted Dec 29, 2020·6 cites·13 claims
- 0685US10905717B2Blood plasma and plasma fractions as therapy for tumor growth and progressionALKAHEST INC·Filed 2019·Granted Feb 2, 2021·5 cites·13 claims
- 0784US11413308B2Dosing regimen for treatment of cognitive and motor impairments with blood plasma and blood plasma productsALKAHEST INC·Filed 2020·Granted Aug 16, 2022·1 cites·19 claims
- 0882US9918980B2Method of treating dyskinesiaUNIV RUTGERS·Filed 2016·Granted Mar 20, 2018·2 cites·10 claims
- 0978US10736889B2Method of treating dyskinesiaUNIV RUTGERS·Filed 2018·Granted Aug 11, 2020·2 cites·19 claims
- 1078US9289423B2Method of treating dyskinesiaMOURADIAN MARY MARAL·Filed 2012·Granted Mar 22, 2016·6 cites·18 claims
- 1173US11040068B2Dosing regimen for treatment of cognitive and motor impairments with blood plasma and blood plasma productsALKAHEST INC·Filed 2019·Granted Jun 22, 2021·1 cites·14 claims
- 1270US2023346764A1Methods and Compositions for Treating Pruritus, Xerosis, and Associated Disease Using CCR3-InhibitorsALKAHEST INC·Filed 2023·Application pending·0 cites
- 1366US2022257590A1Method of treating dyskinesiaUNIV RUTGERS·Filed 2022·Application pending·0 cites
- 1464US2022152161A1Blood Plasma Fractions as a Treatment for Aging-Associated Cognitive DisordersALKAHEST INC·Filed 2022·Application pending·0 cites
- 1563US2021113612A1Blood Plasma and Plasma Fractions as Therapy for Tumor Growth and ProgressionALKAHEST INC·Filed 2020·Application pending·0 cites
- 1661US2021236656A1Methods for screening human blood products comprising plasma using immunocompromised rodent modelsUNIV LELAND STANFORD JUNIOR·Filed 2021·Application pending·0 cites
- 1760US2023069856A1Blood Plasma Fractions for Improvement of MyelinationALKAHEST INC·Filed 2022·Application pending·0 cites
- 1860US2021315932A1Dosing Regimen for Treatment of Cognitive and Motor Impairments with Blood Plasma and Blood Plasma ProductsALKAHEST INC·Filed 2021·Application pending·0 cites
- 1959US2019111042A1Methods and Compositions for Treating Pruritus, Xerosis, and Associated Disease Using CCR-InhibitorsALKAHEST INC·Filed 2018·Application pending·0 cites
- 2052US2005142630A1Interaction of NMDA receptor with the protein tyrosine phosphatase step in psychotic disordersAGY THERAPEUTICS INC·Filed 2004·Application pending·0 cites
- 2150US2019321449A1Blood Plasma Fractions as a Treatment for Aging-Associated Cognitive DisordersALKAHEST INC·Filed 2019·Application pending·0 cites
- 2250US2020054622A1Methods and Compositions for Treating Aging-Associated Impairments Using CCR3-InhibitorsALKAHEST INC·Filed 2019·Application pending·0 cites
- 2348US11382907B2Methods and compositions for treating aging-associated impairments using CCR3-inhibitorsALKAHEST INC·Filed 2018·Granted Jul 12, 2022·0 cites·16 claims
- 2444US2003092071A1Interaction of NMDA receptor with protein tyrosine phosphataseFiled 2002·Application pending·0 cites
- 2537US2015352099A1Compositions and Methods of Reducing SedationMENTINOVA INC·Filed 2015·Application pending·0 cites
- 2636US2005221411A1Interaction of NMDA receptor with the protein tyrosine phosphatase step in psychotic disordersAGY THERAPEUTICS INC·Filed 2005·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →